Uganda: malaria/AIDS drugs "rot in stores"
Members of Uganda's Social Services Committee visiting Entebbe were reportedly "shocked" to discover containers of antimalarial and antiretroviral drugs that had passed expiry dates at a time when thousands of people are unable to access treatment.
The National Medical Stores' General Manager, Apollo Newton Mwesigye, told visiting politicians that HIV/AIDS drugs worth 900.0 million Ugandan shillings ($542,169) and other products valued at 1.2 billion shillings had expired. Mr Mwesigye's predecessor, Robert Rutagi, was suspended for "mismanagement."
One problem, the NMS argues, is the practice of third-parties depositing drug supplies at the agency's Entebbe depot, often with products that are close to their expiry dates. The agency listed the Global Fund, the Clinton Foundation and other agencies concerned with HIV/AIDS and malaria.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze